259 related articles for article (PubMed ID: 20480453)
21. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
Poolman J; Borrow R
Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
[TBL] [Abstract][Full Text] [Related]
22. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
[TBL] [Abstract][Full Text] [Related]
23. Serotype-specific problems associated with pneumococcal conjugate vaccination.
Hanage WP
Future Microbiol; 2008 Feb; 3(1):23-30. PubMed ID: 18230031
[TBL] [Abstract][Full Text] [Related]
24. [Serotype 19F pneumococcal meningitis in an imunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine Prevenar].
Isapof A; Delacourt C; Reinert P; Cohen R; Madhi F
Arch Pediatr; 2009 Aug; 16(8):1133-6. PubMed ID: 19500954
[TBL] [Abstract][Full Text] [Related]
25. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
Traut V
Dtsch Med Wochenschr; 2008 May; 133(22):1207-8; author reply 1208. PubMed ID: 18491279
[No Abstract] [Full Text] [Related]
26. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region.
Pelton SI
Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351
[No Abstract] [Full Text] [Related]
27. Pneumococcal vaccination of adults: polysaccharide or conjugate.
Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
[No Abstract] [Full Text] [Related]
28. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.
Wkly Epidemiol Rec; 2007 Mar; 82(12):93-104. PubMed ID: 17380597
[No Abstract] [Full Text] [Related]
29. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
30. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.
Park SY; Moore MR; Bruden DL; Hyde TB; Reasonover AL; Harker-Jones M; Rudolph KM; Hurlburt DA; Parks DJ; Parkinson AJ; Schuchat A; Hennessy TW
Pediatr Infect Dis J; 2008 Apr; 27(4):335-40. PubMed ID: 18316986
[TBL] [Abstract][Full Text] [Related]
31. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Prymula R
Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
Goldblatt D; Southern J; Ashton L; Richmond P; Burbidge P; Tasevska J; Crowley-Luke A; Andrews N; Morris R; Borrow R; Cartwright K; Miller E
Pediatr Infect Dis J; 2006 Apr; 25(4):312-9. PubMed ID: 16567982
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with pneumococcal conjugate vaccines in infants and children.
Jackson CR
J Am Osteopath Assoc; 2002 Aug; 102(8):431-6. PubMed ID: 12201547
[TBL] [Abstract][Full Text] [Related]
34. Pneumococcal vaccines in adults: assessing the evolving evidence.
Grabenstein JD; Manoff SB
Vaccine; 2011 Aug; 29(37):6149-54. PubMed ID: 21763386
[No Abstract] [Full Text] [Related]
35. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
[TBL] [Abstract][Full Text] [Related]
36. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
37. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal conjugate vaccine for young children.
Zimmerman RK
Am Fam Physician; 2001 May; 63(10):1991-8. PubMed ID: 11388715
[TBL] [Abstract][Full Text] [Related]
39. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
[TBL] [Abstract][Full Text] [Related]
40. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
Joloba ML; Windau A; Bajaksouzian S; Appelbaum PC; Hausdorff WP; Jacobs MR
Clin Infect Dis; 2001 Nov; 33(9):1489-94. PubMed ID: 11588694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
